PubMed:32234451 JSON TXT

Annnotations TAB JSON ListView MergeView

LitCovid-OGER-BB

LitCovid-sentences-v1

{"project":"LitCovid-sentences-v1","denotations":[{"id":"TextSentencer_T1","span":{"begin":0,"end":50},"obj":"Sentence"},{"id":"TextSentencer_T2","span":{"begin":51,"end":62},"obj":"Sentence"},{"id":"TextSentencer_T3","span":{"begin":63,"end":237},"obj":"Sentence"},{"id":"TextSentencer_T4","span":{"begin":238,"end":400},"obj":"Sentence"},{"id":"TextSentencer_T5","span":{"begin":401,"end":646},"obj":"Sentence"},{"id":"TextSentencer_T6","span":{"begin":647,"end":658},"obj":"Sentence"},{"id":"TextSentencer_T7","span":{"begin":659,"end":791},"obj":"Sentence"},{"id":"TextSentencer_T8","span":{"begin":792,"end":800},"obj":"Sentence"},{"id":"TextSentencer_T9","span":{"begin":801,"end":990},"obj":"Sentence"},{"id":"TextSentencer_T10","span":{"begin":991,"end":1082},"obj":"Sentence"},{"id":"TextSentencer_T11","span":{"begin":1083,"end":1180},"obj":"Sentence"},{"id":"TextSentencer_T12","span":{"begin":1181,"end":1323},"obj":"Sentence"},{"id":"TextSentencer_T13","span":{"begin":1324,"end":1409},"obj":"Sentence"},{"id":"TextSentencer_T14","span":{"begin":1410,"end":1498},"obj":"Sentence"},{"id":"TextSentencer_T15","span":{"begin":1499,"end":1669},"obj":"Sentence"},{"id":"TextSentencer_T16","span":{"begin":1670,"end":1683},"obj":"Sentence"},{"id":"TextSentencer_T17","span":{"begin":1684,"end":1812},"obj":"Sentence"},{"id":"TextSentencer_T18","span":{"begin":1813,"end":1958},"obj":"Sentence"}],"text":"COVID-19, SARS and MERS: are they closely related?\nBACKGROUND: The 2019 novel coronavirus (SARS-CoV-2) is a new human coronavirus which is spreading with epidemic features in China and other Asian countries with cases reported worldwide. This novel Coronavirus Disease (COVID-19) is associated with a respiratory illness that may cause severe pneumonia and acute respiratory distress syndrome (ARDS). Although related to the Severe Acute Respiratory Syndrome (SARS) and the Middle East Respiratory Syndrome (MERS), COVID-19 shows some peculiar pathogenetic, epidemiological and clinical features which have not been completely understood to date.\nOBJECTIVES: We provide a review of the differences in terms of pathogenesis, epidemiology and clinical features between COVID-19, SARS and MERS.\nSOURCES: The most recent literature in English language regarding COVID-19 has been reviewed and extracted data have been compared with the current scientific evidence about SARS and MERS epidemics.\nCONTENT: COVID-19 seems not to be very different from SARS regarding its clinical features. However, it has a fatality rate of 2.3%, lower than SARS (9.5%) and much lower than MERS (34.4%). It cannot be excluded that because of the COVID-19 less severe clinical picture it can spread in the community more easily than MERS and SARS. The actual basic reproductive number (R0) of COVID-19 (2-2.5) is still controversial. It is probably slightly higher than the R0 of SARS (1.7-1.9) and higher than MERS (\u003c1),. The gastrointestinal route of transmission of SARS-CoV-2, which has been also assumed for SARS-CoV and MERS-CoV, cannot be ruled out and needs to be further investigated.\nIMPLICATIONS: There is still much more to know about COVID-19, especially as concerns mortality and capacity of spreading on a pandemic level. Nonetheless, all of the lessons we learned in the past from SARS and MERS epidemics are the best cultural weapons to face this new global threat."}

LitCovid-TimeML

LitCovid-PD-HP-v1

{"project":"LitCovid-PD-HP-v1","denotations":[{"id":"T1","span":{"begin":343,"end":352},"obj":"Phenotype"},{"id":"T2","span":{"begin":363,"end":383},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0002090"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0002098"}],"text":"COVID-19, SARS and MERS: are they closely related?\nBACKGROUND: The 2019 novel coronavirus (SARS-CoV-2) is a new human coronavirus which is spreading with epidemic features in China and other Asian countries with cases reported worldwide. This novel Coronavirus Disease (COVID-19) is associated with a respiratory illness that may cause severe pneumonia and acute respiratory distress syndrome (ARDS). Although related to the Severe Acute Respiratory Syndrome (SARS) and the Middle East Respiratory Syndrome (MERS), COVID-19 shows some peculiar pathogenetic, epidemiological and clinical features which have not been completely understood to date.\nOBJECTIVES: We provide a review of the differences in terms of pathogenesis, epidemiology and clinical features between COVID-19, SARS and MERS.\nSOURCES: The most recent literature in English language regarding COVID-19 has been reviewed and extracted data have been compared with the current scientific evidence about SARS and MERS epidemics.\nCONTENT: COVID-19 seems not to be very different from SARS regarding its clinical features. However, it has a fatality rate of 2.3%, lower than SARS (9.5%) and much lower than MERS (34.4%). It cannot be excluded that because of the COVID-19 less severe clinical picture it can spread in the community more easily than MERS and SARS. The actual basic reproductive number (R0) of COVID-19 (2-2.5) is still controversial. It is probably slightly higher than the R0 of SARS (1.7-1.9) and higher than MERS (\u003c1),. The gastrointestinal route of transmission of SARS-CoV-2, which has been also assumed for SARS-CoV and MERS-CoV, cannot be ruled out and needs to be further investigated.\nIMPLICATIONS: There is still much more to know about COVID-19, especially as concerns mortality and capacity of spreading on a pandemic level. Nonetheless, all of the lessons we learned in the past from SARS and MERS epidemics are the best cultural weapons to face this new global threat."}

LitCovid-PD-MONDO-v1

LitCovid-PD-FMA-UBERON-v1

{"project":"LitCovid-PD-FMA-UBERON-v1","denotations":[{"id":"T1","span":{"begin":1930,"end":1934},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma24728"},{"id":"A41172","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0001456"}],"text":"COVID-19, SARS and MERS: are they closely related?\nBACKGROUND: The 2019 novel coronavirus (SARS-CoV-2) is a new human coronavirus which is spreading with epidemic features in China and other Asian countries with cases reported worldwide. This novel Coronavirus Disease (COVID-19) is associated with a respiratory illness that may cause severe pneumonia and acute respiratory distress syndrome (ARDS). Although related to the Severe Acute Respiratory Syndrome (SARS) and the Middle East Respiratory Syndrome (MERS), COVID-19 shows some peculiar pathogenetic, epidemiological and clinical features which have not been completely understood to date.\nOBJECTIVES: We provide a review of the differences in terms of pathogenesis, epidemiology and clinical features between COVID-19, SARS and MERS.\nSOURCES: The most recent literature in English language regarding COVID-19 has been reviewed and extracted data have been compared with the current scientific evidence about SARS and MERS epidemics.\nCONTENT: COVID-19 seems not to be very different from SARS regarding its clinical features. However, it has a fatality rate of 2.3%, lower than SARS (9.5%) and much lower than MERS (34.4%). It cannot be excluded that because of the COVID-19 less severe clinical picture it can spread in the community more easily than MERS and SARS. The actual basic reproductive number (R0) of COVID-19 (2-2.5) is still controversial. It is probably slightly higher than the R0 of SARS (1.7-1.9) and higher than MERS (\u003c1),. The gastrointestinal route of transmission of SARS-CoV-2, which has been also assumed for SARS-CoV and MERS-CoV, cannot be ruled out and needs to be further investigated.\nIMPLICATIONS: There is still much more to know about COVID-19, especially as concerns mortality and capacity of spreading on a pandemic level. Nonetheless, all of the lessons we learned in the past from SARS and MERS epidemics are the best cultural weapons to face this new global threat."}